Molex expands Phillips-Medisize footprint with new Poland facility

Molex, a global electronics and connectivity innovator, has announced expanded its manufacturing footprint with the opening of a new campus in Katowice, Poland. 

The facility’s initial 23,000 square-metre manufacturing space will serve as a strategic central location to help facilitate delivery of advanced medical devices for Phillips-Medisize, as well as electric vehicle and electrification solutions for Molex customers. Future expansion of up to 85,000 square metres is built into Molex’s growth plans for the facility.

Paul Chaffin, Phillips-Medisize SVP and president of Molex Medical and Pharma Solutions, said: “The Katowice campus will expand our European footprint, providing our pharmaceutical, diagnostic and medtech customers with new capabilities and the expert support they need to bring innovative new products to market. This ultimately allows us to further our vision of enabling patients all over the world to live healthier, more productive lives. We look forward to becoming an active part of the local community, as we work together to create significant value for our customers, our new team members and ultimately patients.”

Molex has so far invested $110 million in these world-class facilities that will initially support Phillips-Medisize with production of pharmaceutical, medical, and diagnostic devices. The site's capabilities will include advanced medical device assembly, packaging, drug handling and injection moulding. Additionally, the campus will manufacture interconnect battery solutions for electric vehicles and high-power busbar solutions for Molex’s electrification business.

Katowice will complement Phillips-Medisize’s existing operations at six European manufacturing sites in Donegal and Sligo, Ireland; Struer, Denmark; Trhove Sviny, Czech Republic; and two locations in Kontiolahti, Finland.

The pool of manufacturing and engineering resources in the Katowice area was a factor influencing Molex’s selection of the site location. At planned capacity, the first facilities within the campus will employ approximately 350 employees, including production operators, design engineers and quality specialists.

The campus will be the first site for both Molex and Phillips-Medisize to hold a LEED Gold certification. ISO 13485 certification is pending construction completion, with additional certifications and registrations to follow.